$263.38 +0.13 (%) Shire Shs Sponsored American Deposit Receipt Repr 3 Shs - NASDAQ

Jul. 29, 2015 | 04:00 PM

Partner Headlines

  1. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD | Jul. 29, 2015 | 18:50PM EST
  2. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD | Jul. 28, 2015 | 14:33PM EST
  3. Valeant Posts Princely Gains

    IBD | Jul. 23, 2015 | 18:55PM EST
  4. Shire ups outlook on new drugs

    IBD | Jul. 23, 2015 | 18:50PM EST
  5. Shire Lifts 2015 Guidance On Strong Drug Pipeline

    IBD | Jul. 23, 2015 | 14:42PM EST
  6. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD | Jul. 23, 2015 | 09:37AM EST
  7. Top World Stocks In Bases Or Buy Range As Greece Votes

    IBD | Jul. 15, 2015 | 17:50PM EST
  8. Manning & Napier's Top 5 New Stock Buys of Q2

    GuruFocus | Jul. 9, 2015 | 02:00AM EST
  9. Manning & Napier Invests in Stake in Baidu

    GuruFocus | Jul. 8, 2015 | 17:00PM EST
  10. Andreas Halvorsen Increases Stake in Esperion Therapeutics

    GuruFocus | Jun. 30, 2015 | 00:18AM EST
  11. Daniel Loeb Parts With Stake in Alibaba

    GuruFocus | Jun. 24, 2015 | 19:01PM EST
  12. Smart Guru John Paulson Bullish on Actavis

    GuruFocus | Jun. 18, 2015 | 17:25PM EST
  13. When PIIGS Fly: The Power Of Ireland's Politics

    IBD | Jun. 11, 2015 | 18:54PM EST
  14. Benzinga's Weekend M&A Chatter

    Benzinga | Jun. 7, 2015 | 20:16PM EST
  15. Meet 8 Hot Med Stocks Among IBD's Big Cap Leaders

    IBD | Jun. 3, 2015 | 08:01AM EST
  16. John Paulson's Stocks Trading at Low P/E

    GuruFocus | May. 4, 2015 | 16:59PM EST
  17. Shire Reports A Good Quarter Promoted By Drug Sales

    GuruFocus | May. 4, 2015 | 00:11AM EST
  18. Shire sees double-digit gains

    IBD | Apr. 30, 2015 | 18:42PM EST
  19. Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings

    IBD | Apr. 30, 2015 | 10:48AM EST
  20. Benzinga's Top Initiations

    Benzinga | Apr. 29, 2015 | 09:36AM EST
  21. Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent

    Benzinga | Apr. 20, 2015 | 16:09PM EST
  22. Goldman's Monster Q1 Spurred By Megadeals, Volatility

    IBD | Apr. 16, 2015 | 11:32AM EST
  23. Goldman's Q1 Seen Lifted By Gyrating Stocks, Big M&A

    IBD | Apr. 13, 2015 | 17:26PM EST
  24. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | Mar. 2, 2015 | 07:36AM EST
  25. Cyberonics Soars On Earnings Beat, Tax Inversion Deal

    IBD | Feb. 26, 2015 | 13:58PM EST
  26. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  27. Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals

    GuruFocus | Feb. 24, 2015 | 12:09PM EST
  28. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  29. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  30. Valeant Pharmaceuticals Will Buy Salix For $14.5 Billion

    IBD | Feb. 22, 2015 | 17:46PM EST
  31. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD | Feb. 19, 2015 | 16:59PM EST
  32. A Look At Dan Loeb's Diversified 13F

    Benzinga | Feb. 18, 2015 | 18:04PM EST
  33. Paulson & Company's Q4 Moves: Healthcare And Beyond

    Benzinga | Feb. 18, 2015 | 16:12PM EST
  34. Benzinga's Weekend M&A Chatter

    Benzinga | Feb. 16, 2015 | 17:14PM EST
  35. Three Pharma Majors In The Run To Acquire Salix

    GuruFocus | Feb. 16, 2015 | 12:30PM EST
  36. Salix, Top Drug Stocks Rally As Merger Mania Heats Up

    IBD | Feb. 13, 2015 | 18:08PM EST
  37. Benzinga's M&A Chatter for Thursday February 12, 2015

    Benzinga | Feb. 12, 2015 | 20:18PM EST
  38. Shire rises on NPS potential

    IBD | Feb. 12, 2015 | 18:30PM EST
  39. Shire Moves Higher On NPS Potential; Q4 Earnings Miss

    IBD | Feb. 12, 2015 | 10:45AM EST
  40. Earnings Scheduled For February 12, 2015

    Benzinga | Feb. 12, 2015 | 04:29AM EST
  41. Greece Weighs On Stocks; TripAdvisor Up After Close

    IBD | Feb. 11, 2015 | 16:57PM EST
  42. Pioneer Investments Purchases Time Warner Cable, Kohl's in Q4

    GuruFocus | Feb. 10, 2015 | 14:17PM EST
  43. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 9, 2015 | 08:14AM EST
  44. AbbVie's Q4 Reflects Its Tremendous Growth Potential Going Forward

    GuruFocus | Feb. 4, 2015 | 11:58AM EST
  45. Benzinga's M&A Chatter for Tuesday February 3, 2015

    Benzinga | Feb. 3, 2015 | 18:22PM EST
  46. Top Performing Funds Favor Leisure, Medical, REITs

    IBD | Feb. 3, 2015 | 18:22PM EST
  47. Valeant Could Be Interested In Buying Salix; Sterne Agree Says This Makes Sense

    Benzinga | Feb. 3, 2015 | 16:37PM EST
  48. U.S. Supreme Court Grants Shire Petition

    Benzinga | Jan. 27, 2015 | 17:07PM EST
  49. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jan. 26, 2015 | 07:14AM EST
  50. Greenlight Capital Fourth Quarter Letter To Investors

    GuruFocus | Jan. 22, 2015 | 17:42PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!